Aquilo Capital Management, LLC Regenxbio Inc. Transaction History

Aquilo Capital Management, LLC

  • $100 Million
  • Q2 2024

A detailed history of Aquilo Capital Management, LLC transactions in Regenxbio Inc. stock. As of the latest transaction made, Aquilo Capital Management, LLC holds 906,248 shares of RGNX stock, worth $7.97 Million. This represents 10.6% of its overall portfolio holdings.

Number of Shares
906,248
Previous 906,248 -0.0%
Holding current value
$7.97 Million
Previous $19.1 Million 44.47%
% of portfolio
10.6%
Previous 14.9%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$12.17 - $24.61 $1.26 Million - $2.56 Million
103,824 Added 12.94%
906,248 $19.1 Million
Q4 2023

Feb 14, 2024
SELL
$12.89 - $20.82 $580,050 - $936,900
-45,000 Reduced 5.31%
802,424 $14.4 Million
Q3 2023

Nov 14, 2023
SELL
$16.46 - $19.99 $373,477 - $453,573
-22,690 Reduced 2.61%
847,424 $13.9 Million
Q2 2023

Aug 14, 2023
BUY
$17.23 - $21.71 $673,693 - $848,861
39,100 Added 4.71%
870,114 $17.4 Million
Q1 2023

May 15, 2023
SELL
$18.08 - $24.55 $1.21 Million - $1.64 Million
-66,670 Reduced 7.43%
831,014 $15.7 Million
Q4 2022

Feb 14, 2023
SELL
$20.4 - $24.73 $1.43 Million - $1.73 Million
-70,000 Reduced 7.23%
897,684 $20.4 Million
Q3 2022

Nov 14, 2022
SELL
$22.29 - $35.04 $4.46 Million - $7.01 Million
-200,000 Reduced 17.13%
967,684 $25.6 Million
Q2 2022

Aug 15, 2022
BUY
$19.35 - $35.04 $948,150 - $1.72 Million
49,000 Added 4.38%
1,167,684 $28.8 Million
Q1 2022

May 16, 2022
BUY
$24.62 - $34.31 $2.59 Million - $3.61 Million
105,088 Added 10.37%
1,118,684 $37.1 Million
Q4 2021

Feb 14, 2022
BUY
$30.19 - $40.28 $5.27 Million - $7.03 Million
174,457 Added 20.79%
1,013,596 $33.1 Million
Q3 2021

Nov 15, 2021
BUY
$29.09 - $45.68 $7.09 Million - $11.1 Million
243,695 Added 40.93%
839,139 $35.2 Million
Q2 2021

Aug 16, 2021
BUY
$32.46 - $40.48 $1.17 Million - $1.46 Million
36,000 Added 6.43%
595,444 $23.1 Million
Q1 2021

May 17, 2021
BUY
$33.61 - $49.95 $1.88 Million - $2.8 Million
56,000 Added 11.12%
559,444 $19.1 Million
Q4 2020

Feb 16, 2021
SELL
$26.52 - $49.35 $194,020 - $361,044
-7,316 Reduced 1.43%
503,444 $22.8 Million
Q3 2020

Nov 16, 2020
SELL
$27.01 - $40.26 $1.15 Million - $1.72 Million
-42,693 Reduced 7.71%
510,760 $14.1 Million
Q2 2020

Aug 14, 2020
BUY
$27.75 - $43.44 $7.78 Million - $12.2 Million
280,242 Added 102.57%
553,453 $20.4 Million
Q1 2020

May 15, 2020
BUY
$21.5 - $54.2 $95,309 - $240,268
4,433 Added 1.65%
273,211 $8.85 Million
Q4 2019

Feb 14, 2020
BUY
$34.54 - $44.87 $9.28 Million - $12.1 Million
268,778 New
268,778 $11 Million

Others Institutions Holding RGNX

# of Institutions
199
Shares Held
43.3M
Call Options Held
58.9K
Put Options Held
58.4K
View Full List

About REGENXBIO Inc.

RGNX Quotes by TradingView
  • Ticker RGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,230,000
  • Market Cap $380M
  • Description
  • REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...
More about RGNX
Track This Portfolio

Track Aquilo Capital Management, LLC Portfolio

Follow Aquilo Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aquilo Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aquilo Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email